Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) For Its Solid Oral Formulation Facility (F-4) At Jarod
06:33 PM, 14th Feb 2025
We would like to inform the Exchange that the Company has received an Establishment Inspection Report (EIR) today with classification as Voluntary Action Indicated for its Solid Oral Formulation Facility (F-4) at Jarod.